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Abstract  
Background: Increased therapy has been linked to improvements in functional ability of 
people with stroke. 
Aims: 
To determine the effectiveness of two alternative models of increased physiotherapy service 
delivery (7-day week therapy or group circuit class therapy 5 days a week) to usual care. 
Method: 
Three-armed randomised controlled trial with blinded assessment of outcome. People 
admitted with a diagnosis of stroke, previously independently ambulant and with a moderate 
level of disability were recruited. ‘Usual care’ was individual physiotherapy provided 5 days 
a week. 7-day week therapy was usual care physiotherapy provided 7 days a week. 
Participants in the circuit class therapy arm of the trial received physiotherapy in group 
circuit classes in two 90-minute sessions, 5 days a week. Primary outcome was distance 
walked on the 6-minute walk test at 4 weeks post-randomisation.  
Results:  
283 participants were randomised; primary outcome data were available for 259 (92%).  In 
the 7-day arm participants received an additional 3 hours of physiotherapy and those in the 
circuit class arm an additional 22 hours. There were no significant between-group differences 
at 4 weeks in walking distance (p=0.72). Length of stay was shorter for 7-day (mean 
difference -2.9 days, 95% confidence interval [CI] -17.9 to 12.0) and circuit class participants 
(mean difference  -9.2 days, 95% CI -24.2 to 5.8) compared to usual care, but this was not 
significant.  
Conclusions: Both 7-day therapy and group circuit class therapy increased physiotherapy 
time, but walking outcomes were equivalent to usual care.  
Clinical Trial Registration: 
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URL:https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12610000096
055  Unique identifier: ACTRN12610000096055. 
Introduction 
People in hospital after stroke in Western countries receive between 15 and 60 minutes of 
physiotherapy per day (1, 2).  Evidence from clinical trials (3, 4) and neuroplasticity literature 
(5, 6) suggests that more therapy time will lead to improved functional recovery after stroke. 
However, this hypothesis has not been tested within a robust clinical trial to date, and the 
most effective and cost-effective means of providing increased therapy time is not known. 
Two alternative models for increasing the amount of physiotherapy are group circuit class 
therapy and 7-day week therapy.  
Only around 30% of rehabilitation facilities in Australia currently provide weekend 
physiotherapy services (7). Two randomised controlled trials (RCTs) of additional Saturday 
physiotherapy services (6-days versus 5-days week therapy) have been conducted. In both, 
participants had mixed diagnoses, with between 10% (8) and 16% (9) of the sample 
diagnosed with stroke. In both trials small (3 and 2 days respectively), but non-significant, 
reductions in length of hospital stay were found. In one trial, participants who received 6-day 
week therapy were also found to have greater independence at discharge from hospital (9), 
although the mean between group difference of 2 points on the Functional Independence 
Measure (FIM) was well below the minimal clinically important difference of 22 points (10). 
There are however, no RCTs testing the effectiveness of 7-day week therapy compared to 5-
day week therapy for people with stroke. 
Group circuit class therapy involves stroke survivors receiving physiotherapy services in a 
group setting with a ratio of staff to participants of no more than 1:3. With the group nature 
of the approach, people with stroke are able to spend more time in physiotherapy sessions 
within existing staffing levels. Circuit class therapy has been shown to be effective in 
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increasing therapy time (11) for people receiving inpatient rehabilitation after stroke. To date 
there are eight published RCTs investigating the effectiveness of circuit class therapy, four 
involving participants >6 months after stroke, and four involving participants in the subacute 
phase (< 6 months post-stroke) (3). In the one RCT involving participants receiving inpatient 
rehabilitation (12), participants received circuit class therapy in addition to usual care 
physiotherapy. All other trials were conducted in outpatient settings and compared circuit 
class therapy to no therapy, or sham intervention. These trials were recently synthesised in a 
meta-analysis by Veerbeek et al. (3), who showed a significant, homogenous effect size in 
favour of circuit class therapy for improving walking capacity (distance walked on the 6-
minute walk test), and, to a lesser extent, walking speed. The effect of circuit class therapy on 
improving walking ability was strongest for people at least 6 months post stroke.  
Aims 
Given ongoing pressures to improve the efficiency and cost-effectiveness of models of stroke 
care, we wanted to  examine the effectiveness of group circuit class therapy as an alternative 
model of physiotherapy service delivery to people receiving in-hospital rehabilitation in the 
subacute post-stroke period, as well as test the comparative effectiveness of 7-day versus 5 
days a week therapy. To this end, the aim of this trial was to investigate the effectiveness, in 
terms of physiotherapy time and clinical outcomes, of two alternative models of increasing 
physiotherapy dosage after stroke.  
The primary hypotheses of the study were: 
(1) providing physiotherapy in group circuit classes (5 days a week) will lead to improved 
walking ability compared to usual care physiotherapy (5 days a week) at 4 weeks post-
randomisation (primary outcome) 
(2) providing 7-day a week physiotherapy will lead to improved walking ability compared to 
usual care physiotherapy at 4 weeks post-randomisation, and  
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(3) providing physiotherapy in group circuit classes (5 days a week) will lead to improved 
walking ability compared to 7-day a week physiotherapy at 4 weeks post-randomisation. 
Results of the cost-effectiveness sub-study will be the topic of a future paper.  
Methods 
This was a 3-armed RCT with concealed allocation and blinded assessment of outcome. A 
computer-generated randomisation sequence was blocked to ensure equal numbers for each 
arm in each block of 15. Randomisation was concealed by use of a central telephone service 
administered by staff not involved in the trial. Participants were recruited from one of five 
stroke rehabilitation centres in three states within Australia. Trained assessors who were 
unaware of participant group allocation assessed participants at baseline, 4 weeks, 3 and 6 
months post-randomisation. The trial was registered with the Australian and New Zealand 
Trial Registry (ACTRN12610000096055). Ethical approval was obtained from the University 
of South Australia Human Research Ethics Committee (Protocol P380-09) and from the 
ethics committees governing each recruitment site.   
Participants  
Full details of the trial protocol are published elsewhere (13). Briefly, participants were 
people with stroke admitted to inpatient rehabilitation facilities with moderate disability (FIM 
total score between 40 and 80 points or motor subscale score of between 38 and 62 points) 
(14). Either participants provided informed consent themselves, or proxy consent was 
obtained from an appropriate third party.  
Interventions 
From the time of admission to rehabilitation until randomisation, participants received usual 
care physiotherapy. From the next working day after randomisation, participants received the 
allocated model of physiotherapy service delivery for the duration of their inpatient stay. The 
comparison of interest in this trial was the amount of physiotherapy time provided to people 
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with stroke (13). Therefore the content of therapy sessions was similar between intervention 
arms, and the key differences were the time scheduled for therapy and the mode of therapy 
delivery (individual versus group). 
Usual care therapy 
Participants randomised to usual care received physiotherapy according to local site standard 
practice. For three of the five sites, this was individual sessions provided 5 days a week. At 
two of the recruitment sites usual care involved a combination of daily individual 
physiotherapy sessions augmented for some people by group physiotherapy provided 
between 1 and 4 times a week. In two of the five sites, usual care therapy included weekend 
therapy for some, but not all patients.  
7-day week therapy 
Participants randomised to receive 7-day a week therapy received physiotherapy on both 
Saturday and Sunday for the duration of their inpatient stay, in addition to the usual 5 days of 
the working week. The duration of therapy sessions provided on the weekend was matched to 
that provided during the preceding week. Additional staffing was required to deliver the 7-
day week therapy. 
Circuit class therapy  
Participants received circuit class therapy for up to 3 hours per day, usually in two 90-minute 
sessions, morning and afternoon. Circuit class therapy involved groups of at least three (and 
up to six) participants and was staffed by physiotherapists, assistants and physiotherapy 
students with no more than one staff member to three participants. Where there were less than 
three trial participants randomised to the circuit class arm of the trial at any given time, non-
trial patients with mobility issues were included in circuit class therapy sessions. Training of 
trial staff in the provision of circuit class therapy included a half-day workshop conducted at 
each recruitment site before commencement of the trial. A written manual and ongoing 
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advice and support was provided by the trial manager. Circuit class therapy sessions were not 
run according to a strict protocol. Training was intended to guide therapists in how best to 
adapt their usual practices to providing therapy within the semi-supervised, group nature of 
circuit class therapy sessions.  Therapists were encouraged to prescribe exercises and 
activities that were task-specific, included part- as well as whole- practice of tasks, with an 
emphasis on repetition and feedback. Circuit class therapy was provided within existing 
staffing levels at all sites.  
Fidelity measures 
We monitored the integrity of the interventions provided by asking physiotherapists to record 
details of each therapy session at the end of each session. Therapy data included the duration 
of the session, reasons for missed or shortened sessions, number of staff involved, and in the 
case of circuit class therapy, the total number of patients per class. Therapists’ recall of time 
spent in specific activities within therapy sessions has been proven inaccurate (15). Therefore 
we collected data on the content of therapy sessions by video-taping therapy sessions of all 
available participants on selected days during four time periods (16). The time periods and 
specific days on which therapy sessions were videoed were based on research assistant staff 
availability. 
Outcomes  
All outcomes were assessed by a trained assessor who was blinded to group allocation. All 
assessors were physiotherapists who received specific training in the outcome measures 
collected. To preserve blinding, all assessments took place in a location remote to the usual 
therapy area within the rehabilitation centres. Once discharged, participants returned to the 
rehabilitation centre for assessments. All outcomes were assessed at baseline, 4 weeks after 
randomisation, and at 3 and 6 months after randomisation (with the exception of the Stroke 
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Impact Scale (SIS) and the Australian Quality of Life (AQoL) scale which were not collected 
at baseline). 
 
Demographic data collected included gender, age, time of stroke, history of previous stroke 
and other co-morbidities, side of stroke lesion, Oxfordshire Stroke Classification, cognitive 
function (Mini-mental State Assessment) and screening for visual inattention (star 
cancellation test).  
Primary outcome 
The primary outcome measure was the 6-minute walk test using a standard protocol at 4 
weeks post-randomisation. The 6-minute walk test is a valid and reliable measure of walking 
capacity (17) and previous trials have demonstrated that circuit class therapy is particularly 
effective for improving walking capacity after stroke (3). Participants were provided with 
physical assistance of up to 2 people to complete the 6-minute walk test. Where the test was 
unable to be attempted for safety reasons, a score of 0m was recorded. 
Secondary outcomes 
Walking speed – was measured using a stop watch over the middle 5 metres of a 9 metre 
walkway (18). The first 9 metres walked in the 6-minute walk test was used to assess walking 
speed.  
Degree of independence in walking – was measured using the Functional Ambulation 
Classification (FAC) (19). This ordinal scale rates how much physical assistance a person 
needs to safely walk from a score of 0 (2 people required to assist, or not safe to attempt) to 5 
(independent and safe, including over outdoor surfaces and stairs). 
Independence in activities of daily living was assessed using the FIM (20) which, according 
to the guidelines, was scored by the multidisciplinary team.  
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Arm function was assessed using the Wolf Motor Function test (WMFT), mean time score 
(21).  
Self-reported physical function – was assessed using the SIS physical subscale (22).  
Length of hospital stay – was measured by the number of overnight stays in the rehabilitation 
facility.  
Health related quality of life was measured using the AQoL tool (23).  
Complications and adverse events were monitored throughout the trial for all participants. An 
independent data safety monitor reviewed unblinded data with regard to adverse events and 
complication rates annually during the trial.  
Resource utilisation data, including costs of providing therapy, equipment, length of stay and 
other costs were collected for the purposes of economic evaluation which will be reported 
separately. 
Sample size 
Based on a previous RCT, we predicted a between group difference of 116m (SD 112m) on 
the 6minWT between the circuit class therapy and usual care arms of the trial (13). We 
conservatively estimated the difference in the 7-day week therapy arm compared to usual 
care would be half that seen in the circuit class therapy arm. Based on two-sided independent 
t-tests with Type I error set at 0.025 to allow for multiple testing, a sample size of 75 per arm 
was required to provide at least 80% power to test for differences between circuit class 
therapy and usual care, 7-day therapy and usual care and circuit class therapy and 7-day 
therapy. Importantly, this sample size was sufficient to detect the minimal clinically 
important difference of 50m on the 6mWT (24). Allowing for a 20% drop out rate, we aimed 
to recruit 282 participants. 
Data analysis 
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Data were examined for normality using the Shapiro-Wilk test. As data for all outcome 
measures were not normally distributed at either baseline or 4 weeks, they were analysed 
using non-parametric statistics. To address the primary hypothesis of between group 
differences in walking capacity we conducted a Kruskal-Wallis test. Secondary analyses 
included testing for between group differences at 4 weeks using the chi-squared statistic for 
the FAC categories, and Kruskal-Wallis tests for all other secondary outcomes. Linear mixed 
effects modelling was used to examine change scores between groups between baseline and 4 
weeks for the 6-minute walk test, gait speed, FIM (total), FIM (motor), and WMFT (time 
score). In particular, the group-time interaction effect was used to formally test any 
intervention effect. Linear effects mixed modelling explicitly adjusts for baseline scores by 
modelling change scores for all participants. Analyses were first conducted with no 
imputation of missing data (reported). We then applied multiple imputation (Stata 13 mi 
command with multivariate normal approach), which did not alter the significance of the 
results. Analyses were conducted using SPSS Statistics 21 and Stata 13. 
Results 
Between July 2010 and June 2013, 283 participants were randomly assigned to usual care 
(n=94), 7-day week therapy (n=96) and circuit class therapy (n=93). During this time 
approximately 1,031 people with stroke were admitted to the participating rehabilitation 
centres. Reasons for exclusion included: admission FIM score outside of the eligible range 
(n=489); not independent in walking prior to stroke (n=12); did not consent (n=135); 
medically unstable (n=32); and planned length of rehabilitation stay of less than 2 weeks 
(n=23). The reason for exclusion was not documented in 57 cases. Of the 283 included 
participants, 13 did not complete the 4-week assessment (5 lost to follow-up, 8 withdrawals 
due to death [n=2], poor health [n=2] or refused assessment [n=4]), see Figure 1.  
Intervention fidelity 
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Over the 4-week period, participants in the usual care arm received a mean of 15.1 ± 6.7 
hours of physiotherapy, 7-day week therapy participants received a mean of 18.2 ± 6.0 hours 
of physiotherapy and circuit class therapy participants received a mean of 37.3 ± 12.5 hours 
of physiotherapy. These differences were significant between all three groups (p<0.001 for 
circuit class therapy v usual care and circuit class therapy v 7-day therapy; p=0.044 for usual 
care v 7-day therapy), and are reported in full elsewhere (25). The average number of 
participants per circuit class session was 3.9 ± 1.5.  Four usual care participants received 
additional weekend therapy (mean 1.65 [1.23] hours total weekend therapy per participant). 
A total of 79 therapy sessions (34 usual care and 45 circuit class therapy) were videoed. 
Details about the content of therapy sessions are published elsewhere (15,16). 
There were 13 documented cases of variation to the intervention protocol. Reasons included 
reducing frequency of physiotherapy input while awaiting residential care placement (n=6), 
or on medical orders (n=1), infectious conditions preventing group therapy (n=2), or not 
tolerating the group environment (n=1). In the circuit class arm of the trial, 3 participants 
only received one circuit class therapy session per day due to either fatigue (n=2) or to allow 
adequate time for other therapies (n=1).  
Table 1 presents the demographics of the sample. Groups were balanced at baseline in 
regards to age, sex, stroke type, lesion location and FIM scores. The mean time between 
stroke onset and randomisation was 28.1 ± 21.5 days and was similar across groups.  
Adverse event data are reported in Table 1. The data safety monitor determined that no 
serious adverse events were related to the intervention, with the exception of one calf 
haematoma of unknown cause. Despite the semi-supervised nature of the circuit class 
sessions, there were only 4 falls during therapy sessions reported in this group. None of the 
reported falls in therapy time for any participants caused injury requiring intervention.  
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Double data entry was conducted for a randomly selected sample of participants (10% of total 
sample). There were 13 errors identified within the 1860 data points re-entered (0.7% error 
rate). 
Outcomes 
At baseline 75 (26.6%) participants could not complete the 6-minute walk test, even with the 
assistance of 2 people. At 4 weeks, 13 (5.0%) could not complete the assessment. This 
contributed to 6-minute walk test data being highly skewed at both time points. Table 2 
summarises all outcome measures.  
Between group differences at 4 weeks post-randomisation 
At 4 weeks, distances walked on the 6-minute walk test for each participant group were: 
usual care median 105.5m (IQR197.5), 7-day median 108.0m (IQR 145.0), circuit class 
therapy median 116.0m (IQR 179.0).  There were no significant between group differences at 
4 weeks. Similarly, there were no significant differences between groups at 4 weeks in 
walking speed, independence in walking (FAC), independence in activities of daily living 
(FIM), arm function (WMFT timed tasks), self-reported physical function (SIS-physical) or 
quality of life (AQoL), see Table 2. Length of rehabilitation stay did not differ significantly 
between groups (p=0.643), although compared to usual care, participants in the 7-day arm of 
the trial had a mean 2.9 days shorter length of stay (95% CI -17.9 to 12.0) and participants in 
the circuit class arm of the trial had a mean 9.2 days shorter length of stay (95% CI -24.2 to 
5.8). 
Change over time and between group differences in change scores 
Results of the linear mixed effects model for the 6-minute walk test found that neither of the 
two interaction terms (7 day versus usual care, p=0.899; circuit class versus usual care, 
p=0.344) were statistically significant, implying no intervention effect. When the interaction 
terms were removed from the model, a statistically significant time effect demonstrated that 
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participants in all three groups walked significantly further on the 6-minute walk test at 4 
weeks compared to baseline (p<0.001), however, there were no statistically significant 
differences between groups. Similarly, the interaction effects for gait speed, FIM total, FIM 
motor and WMFT time scores were not statistically significant (p>0.05), implying no effect 
of the intervention. However, for each of these measures, all groups improved significantly 
between baseline and 4 weeks (p<0.001). 
Discussion 
A recent large meta-analysis of clinical trials (3) and a meta-regression analysis of individual 
data from clinical trials (4) both concluded that more therapy time would lead to 
improvements in stroke recovery. Our study is the only adequately powered, high quality 
randomised controlled trial that has tested this assumption in a clinical environment. It is also 
the first RCT to examine the use of group circuit class therapy as an alternative model of 
service delivery, and the first RCT of 7-day week physiotherapy for people receiving in-
hospital rehabilitation after stroke. Despite the substantial increase in therapy time (an extra 3 
hours over 4 weeks for 7-day week participants and an extra 22 hours over 4 weeks for circuit 
class therapy participants) there were no differences between groups in walking ability, arm 
function or activities of daily living at 4 weeks post-randomisation.  This neutral trial result 
has important implications for clinical practice.  
The results of a meta-analysis of 20 RCTs of a range of therapy interventions published by 
Kwakkel (26) suggested there was a threshold of at least an extra 16 hours of additional 
therapy time provided in the first 6 months after stroke that was needed to show improvement 
in outcome. In a recent update of this meta-analysis, including 80 trials of different 
physiotherapy dosage this threshold estimate was adjusted to a minimum of 17 hours (3). In 
our study this minimum threshold of increased therapy time was not just met but exceeded, 
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with no apparent benefit in functional outcome. Two factors may go some way toward 
explaining this unexpected result.  
Firstly, the influence of time alone on recovery of function may have confounded results. 
Subgroup analyses within the meta-analysis by Veerbeek et al. (3) showed that the effect of 
increased therapy time provided less than 6 months after stroke was not significant for many 
outcomes (activities of daily living, walking capacity, arm function), although a significant 
effect remained for walking speed. Therefore, the evidence for more therapy time leading to 
improved functional outcomes is strongest for stroke survivors who are more than 6 months 
post-stroke. Our participants were on average 28 days post-stroke at baseline. The rate of 
recovery after stroke appears to be fastest in the first 3 to 6 months (27, 28). The relative 
influence of time alone and therapy input is difficult to ascertain in rehabilitation trials where 
all participants receive some form of therapy and there have been very few trials conducted 
early after stroke involving a control group which receives no therapy input. However, a 
recent Cochrane review (29) included 55 such trials, 44 of which were conducted in China. In 
all of these trials, significant benefit was found in favour of those receiving rehabilitation. 
While there were considerable risks of bias noted in these trials, this does provide some 
evidence that rehabilitation provides additional benefit above natural recovery. The meta-data 
review by Lohse and colleagues (4) supports this view. In their model, they found that 
amount of therapy was a significant predictor of outcome, regardless of timing post-stroke 
(4). Clearly, the relative influences of time alone and therapy input on post-stroke recovery 
are likely to be complex. Our trial was not powered to undertake sub-group analyses. The 
interrogation of multiple large, robust datasets using meta-analytical approaches are required 
if we are to better understand this relationship.  
The variability in our study sample may have also influenced results. As we were aiming to 
maximise the generalizability of the results, we wanted to determine whether circuit class 
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therapy or 7-day week therapy was beneficial for most stroke survivors in rehabilitation. 
Therefore, our inclusion and exclusion criteria were kept deliberately broad and our final 
sample was more heterogeneous and lower functioning than participants in other circuit class 
therapy (3) or 7-day week therapy trials (8, 9).   
 
The content of therapy sessions – that is, what participants actually did during therapy time – 
was a likely factor in the observed outcome of the trial. The video-taped therapy sessions 
collected as a measure of trial fidelity were analysed in detail and have been published 
elsewhere (15, 16). As expected the content of each therapy session was similar in terms of 
the types of activities and exercises undertaken by the participants. However, despite the 
significantly longer average duration of circuit class therapy sessions (73 minutes compared 
to 35 minutes for usual care sessions), participants spent the same amount of time practising 
walking; 12 minutes in the usual care sessions and 11 minutes in the circuit class therapy 
sessions. The extra therapy time in circuit classes was spent resting (additional 14 minutes), 
in activities involving the affected upper limb (additional 5 minutes), in activities performed 
in a sitting or lying position (additional 9 minutes), and in standing activities (additional 5 
minutes). While this is only a snapshot of all of the therapy sessions provided within the trial, 
it suggests that the dose of walking practice may have been similar between the arms of the 
trial. Therefore, while circuit class therapy was effective at increasing the amount of time 
spent in physiotherapy sessions, it did not appear to be effective at increasing the amount of 
time spent practicing walking. Further work is also required to optimise the intensity (amount 
of practice) that stroke survivors are able to achieve during physiotherapy sessions. 
Evidence from studies investigating the drivers of positive neuroplasticity suggest that the 
type of practice is as important as the amount of practice – salience, relevance, variety and the 
right level of difficulty are all essential components (30). While both circuit class therapy and 
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7-day week therapy can increase the opportunities for an increase in the amount of practice, 
we also need to know more about what the most effective exercises and activities are for 
stroke survivors to perform during physiotherapy sessions for promoting recovery of 
function, and how to optimally tailor and progress these exercises according to individual 
need. The semi-supervised nature of circuit class therapy presents unique challenges to 
therapists to be able to prescribe exercises and activities for their patients that are sufficiently 
challenging enough, yet safe to perform semi-independently.  
Our trial is the first to examine the effectiveness of 7-day week therapy services for stroke 
survivors within a RCT. We found equivalent benefit in this approach in terms of walking 
ability, arm function or length of hospital stay. It is important to note this trial was conducted 
within sub-acute rehabilitation facilities and participants were on average 28.1 (21.5) days 
post-stroke at the time of randomisation. The benefit of providing additional weekend 
physiotherapy services to people early after stroke remains largely untested, but may be an 
important factor in increasing therapy intensity early after stroke (31).  The question of 
rehabilitation services in general being available over the weekend (for discharge/admission) 
and the potential value for patients in terms of increasing activity were beyond the scope of 
this trial.   
Strengths and limitations 
While there were no statistically significant differences between groups, participants in the 
circuit class arm of the trial walked further on the 6-minute walk test compared to both usual 
care and 7-day week participants. This suggests the possibility that our trial may have been 
under-powered. Our sample size calculations were based on the best available evidence about 
expected effect of circuit class therapy on walking capacity in the subacute period after stroke 
(12). However, these data were based on a single centre RCT, and included participants who 
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were all able to walk at baseline (12). Therefore, our sample size may have been overly 
optimistic.  
Few previous physiotherapy dosage studies have included detailed description of the content 
of physiotherapy sessions provided. The detailed analysis of the content of therapy provided 
within this trial (32) allowed further insights into the results. In all, an estimated 80 
physiotherapists were involved in providing therapy in the trial, across five sites and three 
states of Australia. Thus, the therapy provided can be considered generalizable to current 
practice in Australia.  
As this was a trial delivered within existing service settings and physiotherapy practice, the 
content of the therapy sessions was not proscribed. The actual planning and prescription of 
activities and exercises was the responsibility of the treating therapists, all of whom were 
experienced practitioners. The research question was about the delivery model, not the 
content of the physiotherapy sessions. We aimed to answer the question “should circuit class 
therapy or 7-day week therapy be used as the primary mode of physiotherapy service 
delivery?” Based on the trial results, in regards to walking ability, we found that that neither 
circuit class therapy nor 7-day week therapy was superior to usual care physiotherapy.  
There are equivalent benefits, in terms of walking ability, arm function or length of stay, in 
providing therapy over 7-days, or in circuit classes for people receiving rehabilitation early 
after stroke. Providing therapy in group circuit classes and over 7-days does lead to a 
significantly greater amount of physiotherapy time being provided, but increasing time spent 
in therapy alone does not translate to improvements in outcome. This is possibly because the 
extra therapy time did not translate to more time in walking practice during, and outside of 
therapy sessions. Close attention needs to be paid to the type and level of activities and 
exercises that stroke survivors perform during therapy sessions if functional outcome is to be 
improved. 
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Table 1 Baseline characteristics of participants.   
Characteristic 
N(%) or mean ± 
SD, range 
Whole sample  
(n=283) 
Usual care  
(n=94) 
7-day week 
therapy 
(n=96) 
Circuit class 
therapy (n=93) 
Age (years)  
 
69.9 ± 12.7 
23 to 93 
68.2 ± 13.5 
23 to 91 
71.9 ± 12.0 
38 to 91 
70.0 ± 12.9 
34 to 93 
Males  167 (59.0%) 52 (55.3%) 59 (61.5%) 56 (60.2%) 
Females  116 (41.0%) 42 (44.7%) 37 (38.5%) 37 (39.8%) 
First stroke 229 (81.0%) 75 (80.6%) 78 (81.3%) 76 (83.5%) 
Side of stroke 
lesion  
    
     Left 119 (42.0%) 38 (40.4%) 41 (42.7%) 40 (43.0%) 
     Right 142 (50.2%) 46 (48.9%) 47 (49.0%) 49 (63.4%) 
     Brainstem 5 (1.8%) 3 (3.2%) 2 (2.1%) 0 (0%) 
     Combination 11 (3.9%) 4 (4.3%) 4 (4.2%) 3 (3.2%) 
     No lesion on 
imaging 
3 (1.1%) 1 (1.1%) 2 (2.1%) 0 (0%) 
     Unknown 3 (1.1%) 2 (2.1%) 0 (0%) 1 (1.1%) 
Stroke type 
(Oxfordshire 
Stroke 
Classification) 
    
    TACI 41 (14.5%) 15 (16.1%) 9 (9.6%) 17 (18.9%) 
    PACI 108 (38.2%) 31 (34.4%) 40 (42.6%) 37 (41.1%) 
     LACI 49 (17.3%) 16 (17.2%) 20 (21.3%) 13 (14.4%) 
     POCI 20 (7.1%) 11 (11.8%) 5 (5.3%) 4 (4.4%) 
     Haemorrhage 54 (19.1%) 18 (19.4%) 19 (20.2%) 17 (18.9%) 
     Unknown  11 (3.9%) 3 (3.2%) 1 (1.1%) 5 (5.4%) 
Time between 
stroke and 
randomisation to 
trial 
28.1 ± 21.5 
5 to 197 
28.7 ± 17.4 
8 to 121 
25.0 ± 17.2 
6 to 133 
30.9 ± 28.2 
5 to 197 
Previous walking     
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ability 
     Independent 227 (80.2%) 75 (80.9%) 75 (78.1%) 77 (83.4%) 
Independent 
with walking 
aid 
55 (19.1%) 19 (20.2%) 21 (21.9%) 15 (16.3%) 
Unilateral spatial 
neglect  
Star cancellation 
test score ≤ 44 
54 (19.9%) 13 (14.4%) 19 (20.4%) 22 (25.0%) 
MMSE 23.9 ± 5.7 
1 to 30 
24.7 ± 4.5 
3 to 30 
23.6 ± 6.0 
1 to 30 
23.7 ± 5.9 
6 to 30 
TACI= total anterior circulation infarct, PACI = partial anterior circulation infarct, LACI = 
lacunar infarct, POCI = posterior circulation infarct, MMSE = Mini-Mental State 
Examination  
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Table 2 Primary and secondary outcomes at baseline     
Characteristic 
N(%) or mean ± 
SD, range 
Whole sample  
(n=283) 
Usual care  
(n=94) 
7-day week 
therapy 
(n=96) 
Circuit class 
therapy (n=93) 
Primary 
outcomes 
    
6-min walk test 
(m) 
Median ± IQR, 
range 
33.4 ± 106.0 
0 to 400 
31.3 ± 120.0 
0 to 280 
38.8 ± 93.2 
0 to 360 
33.0 ± 110.4  
0 to 400 
Secondary 
outcomes 
    
Gait speed (m/s) 
Median ± IQR, 
range 
0.17 ± 0.43 
0 to 1.20 
0.14 ± 0.47 
0 to 1.20 
0.17 ± 0.36 
0 to 0.91 
0.16 ± 0.44 
0 to 1.00 
FAC n (%)   1.1 ± 1.3 
1.2 0 to 5 
1.1 ± 1.4 
1.2 0 to 5 
1.0 ± 1.4  
0 to 4 
Score 0 150 (53.0%) 47 (50.0%) 50 (50.2%) 53 (57.0%) 
Score 1 28 (9.9%) 7 (7.4%) 12 (12.5%) 9 (9.7%) 
Score 2 48 (17.0%) 22 (23.4%) 15 (15.6%) 11 (11.8%) 
Score 3 40 (14.1%) 14 (14.9%) 12 (12.5%) 15 (15.1%) 
Score 4 15 (5.3%) 3 (3.2%) 6 (6.3%) 6 (6.5%) 
Score 5 2 (0.7%) 1 (1.1%) 1 (1.0%) 0 (0%) 
FIM total (n=283) 
Median ± IQR, 
range 
66.0 ± 22.0 
40 to 112 
67.5 ± 23.5 
40 to 103 
65.0 ± 22.5 
40 to 112 
65.0 ± 18.0 
40 to 98 
FIM motor 
(n=283) 
Median ± IQR, 
range 
40.0 ± 22.0 
15 to 78 
40.8 ± 13.4 
15 to 68  
40.4 ± 13.6 
16 to 78 
40.2 ± 12.1 
18 to 64 
WMFT mean time 
(secs) n=270  
Median ± IQR, 
57.9 (108.9) 
1.4 to 121 
45.9 (90.2) 
1.37 to 121 
66.6 (107.3) 
1.8 to 121 
63.0 (109.6) 
1.72 to 121 
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range 
Adverse events   (n)     
All adverse events  49 12 16 21 
Serious adverse 
events  
16 6 6 4 
Falls during 
physiotherapy 
sessions 
8 0 4 4 
Total number of 
falls  
18 1 7 10 
FAC = Functional Ambulation Classification, FIM = Functional Independence Measure, 
WMFT = Wolf Motor Function Test  
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Table 3 Outcomes at 4 weeks for participants randomised to usual care, 7-day week 
therapy or circuit class therapy. Means and standard deviations   
 Usual care 
therapy  
7-day week 
therapy  
Circuit 
class 
therapy  
p value 
(Kruskal-Wallis 
test)  
Primary outcome     
6-min walk test (m) (n=261) 
Median ± IQR, range 
105.5 ± 
197.5 
0 to 99.9 
108.0 ± 
145.0 
0 to 563 
116.0 ± 
179.0 
0 to 450 
0.997 
Secondary outcomes     
Gait speed (m/s) (n=258)  
Median ± IQR, range 
0.48 ± 0.67 
0.0 to 2.08 
0.42 ± 0.54 
0 to 2.77 
0.48 ± 0.60 
0 to 1.66 
0.967 
FAC n (%) (n=259)     
Score 0 16 (18.2%) 13 (14.8%) 18 (21.7%) 0.709* 
Score 1 7 (8.0%) 4 (4.5%) 4 (4.8%) 
Score 2 15 (17.0%) 10 (11.4%) 10 (12.0%) 
Score 3 10 (11.4%) 17 (19.3%) 16 (19.3%) 
Score 4 24 (27.3%) 24 (27.3%) 17 (18.3%) 
Score 5 16 (18.2%) 20 (22.7) 18 (21.7%) 
FIM total score (n=261) 96.0 ± 36.0 
49 to 126 
100.0 ± 33.5  
41 to 125 
93.0 ± 35.8 
46 to 125 
0.439 
FIM motor score (n=261) 67.5 ± 33.0  
23 to 93 
69.0 ± 30.0 
22 to 91 
64.0 ± 33.8 
23 to 91 
 
WMFT (mean time) (secs) 
(n = 248) 
Median ± IQR, range 
27.6 (109.0)  
2 to 121 
 
12.6 (65.0) 
2 to 121 
 
16.8 (99.0) 
2 to 121 
 
0.45 
SIS – Physical Domain score 
(n = 206) 
Median ± IQR, range 
49.0 (41.4) 
8.3 to 99.4 
51.0 (39.0) 
15.4 to 95.9 
45.9 (36.9) 
9.7 to 100 
0.864 
SIS – recovery score (% 
recovery) (n = 242) 
50.0 (40.0) 
0 to 90 
50.0 (40.0) 
10 to 100 
50.0 (30.0) 
0 to 100 
0.681 
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Median ± IQR, range 
AQoL overall score (n = 
241) 
Median ± IQR, range 
0.24 (0.47) 
-0.2 to 1.0 
0.2 (0.40) 
-0.2 to 1.0 
0.22 (0.38) 
-0.3 to 1.0 
0.991 
LoS (actual discharge date) 
days (n=265) Median ± IQR, 
range 
55.0 ± 49.0 
14 to 240 
45.0 ± 38.0 
14 to 460 
46.0 ± 38.0  
13 to 118 
0.643 
*Chi-squared statistic 
FAC = Functional Ambulation Classification, FIM = Functional Independence Measure, 
WMFT = Wolf Motor Function Test, SIS = Stroke Impact Scale, AQoL = Australian Quality 
of Life, LoS = length of stay 
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Figure 1 – CONSORT statement flow chart 
Assessed for eligibility 
n = 1,031 
Excluded n =748 
Did not meet inclusion criteria 
n=501  
Unwilling/ unable to participate 
n=167  
Planned length of rehabilitation 
stay of < 2 weeks n=23 
Reason not documented n=57 
 
 
  
Randomised 
n = 283 
Allocated usual care therapy 
n = 94 
Allocated 7-day week therapy 
n = 96 
Allocated usual care 
n = 93 
Completed 4 week assessment  
n = 88 
(withdrew n=1, unable/ unwilling 
to attend assessment appointment 
n=5) 
Completed 4 week assessment  
n = 87 
(withdrew n=2, unable/unwilling 
to attend assessment appointment 
n=7) 
Completed 4 week assessment  
n = 84 
(withdrew n=2, unable/unwilling 
to attend assessment appointment 
n=7) 
